Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci, and other Gram-positives in healthcare
- 1 August 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 25 (4) , 385-394
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterocci (VRE) are the two most common healthcare-associated multidrug-resistant organisms. The purpose of this article is to review recent data regarding the epidemiology, control and treatment of these organisms as well as to discuss the emergence of additional antimicrobial resistance determinants. Although the prevalence of methicillin resistance continues to increase among healthcare-associated S. aureus isolates, the incidence of invasive MRSA infections appears to be decreasing. Reduced susceptibility to vancomycin among MRSA isolates has been associated with glycopeptide treatment failure. Resistance to newer antimicrobial agents, such as daptomycin and linezolid, has been described among isolates of MRSA and VRE, further complicating treatment of infections caused by these organisms. Recent studies that have attempted to assess the efficacy of a variety of strategies for the prevention of MRSA and/or VRE transmission and infection, including active surveillance testing, have been published and additional studies are currently underway. MRSA and VRE remain important causes of morbidity and mortality among patients receiving healthcare. The emergence of resistance to additional antimicrobial agents highlights the importance of effective prevention programs. Further study to determine the optimal approaches to treatment and prevention is needed.Keywords
This publication has 71 references indexed in Scilit:
- LEADER Program Results for 2009: an Activity and Spectrum Analysis of Linezolid Using 6,414 Clinical Isolates from 56 Medical Centers in the United StatesAntimicrobial Agents and Chemotherapy, 2011
- International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009American Journal of Infection Control, 2010
- Epidemiology of Healthcare-Associated Bloodstream Infection Caused by USA300 Strains of Methicillin-ResistantStaphylococcus aureusin 3 Affiliated HospitalsInfection Control & Hospital Epidemiology, 2009
- Methicillin-Resistant Staphylococcus aureus Central Line–Associated Bloodstream Infections in US Intensive Care Units, 1997-2007JAMA, 2009
- Emergence of Community-Associated Methicillin-ResistantStaphylococcus aureusStrains as a Cause of Healthcare-Associated Bloodstream Infections in KoreaInfection Control & Hospital Epidemiology, 2009
- Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007Infection Control & Hospital Epidemiology, 2008
- Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United StatesJAMA, 2007
- Community-associated Methicillin-resistantStaphylococcus aureusIsolates and Healthcare-Associated Infections1Emerging Infectious Diseases, 2007
- Community-Associated Strains of Methicillin-ResistantStaphylococccus aureusas the Cause of Healthcare-Associated InfectionInfection Control & Hospital Epidemiology, 2006
- Emergence of Community-Associated Methicillin-Resistant Staphylococcus aureus USA300 Genotype as a Major Cause of Health Care--Associated Blood Stream InfectionsClinical Infectious Diseases, 2006